We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pherecydes Pharma Secures DGA Funding

News   Jan 19, 2012

 
Pherecydes Pharma Secures DGA Funding
 
 
 

RELATED ARTICLES

The "Secret Weapon" of Virus-Neutralizing Antibodies

News

A new study in mice has explored why certain antibodies are highly effective in protecting the body against debilitating viruses like chikungunya.

READ MORE

Multi-organ "Human-on-a-Chip" Enables Long-term Toxicology Testing

News

The microfluidic device with interlinking modules containing human-derived heart, liver, skeletal muscle and nervous system cells was able to maintain cellular viability and record cellular function in real-time for 28 days.

READ MORE

Two HPV Types Linked to Cervical Cancer Have Declined Since Arrival of the HPV Vaccine

News

An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus (HPV) that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease, according to newly published research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE